Home>>Signaling Pathways>> Proteases>> Mitochondrial Metabolism>>Kresoxim-methyl

Kresoxim-methyl

Catalog No.GC47531

A fungicide

Products are for research use only. Not for human use. We do not sell to patients.

Kresoxim-methyl Chemical Structure

Cas No.: 143390-89-0

Size Price Stock Qty
25 mg
$60.00
In stock
50 mg
$108.00
In stock
100 mg
$180.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Kresoxim-methyl is a strobilurin fungicide.1 It inhibits conidial germination of V. inaequalis isolates from apple orchards (EC50s = 0.00033-0.0078 mg/L). Kresoxim-methyl also inhibits mycelial growth (EC50 = 0.240 mg/L) and is fungicidal against Saprolegnia (MIC = 1 mg/L).2 It increases intracellular calcium levels and disrupts the mitochondrial membrane potential in mouse cortical cultures in a concentration-dependent manner.3 Kresoxim-methyl is toxic to goldfish (C. auratus; LC50 = 0.807 mg/L).2

1.Fiaccadori, R., Cicognani, E., Alberoni, G., et al.Sensitivity to strobilurin fungicides of Italian Venturia inaequalis populations with different origin and scab controlPest Manag. Sci.67(5)535-540(2011) 2.Hu, X.-G., Liu, L., Hu, K., et al.In vitro screening of fungicidal chemicals for antifungal activity against SaprolegniaJ. World Aquac. Soc.44(4)528-535(2013) 3.Regueiro, J., OlguÍn, N., Simal-GÁndara, J., et al.Toxicity evaluation of new agricultural fungicides in primary cultured cortical neuronsEnviron. Res.14037-44(2015)

Reviews

Review for Kresoxim-methyl

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Kresoxim-methyl

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.